HIC
ABBV icon

Harvey Investment Company’s AbbVie ABBV Stock Holding History

Harvey Investment Company’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.3M Sell
76,719
-2,367
-3% -$509K 2.1% 20
2026
Q1 		$17.2M Hold
79,086
– – 1.89% 22
2025
Q4 		$18.1M Sell
79,086
-50
-0.1% -$11.4K 1.92% 21
2025
Q3 		$18.3M Hold
79,136
– – 1.96% 20
2025
Q2 		$14.7M Hold
79,136
– – 1.61% 23
2025
Q1 		$16.6M Hold
79,136
– – 1.84% 20
2024
Q4 		$14.1M Sell
79,136
-980
-1% -$180K 1.62% 24
2024
Q3 		$15.8M Hold
80,116
– – 1.79% 24
2024
Q2 		$13.7M Sell
80,116
-725
-0.9% -$120K 1.64% 25
2024
Q1 		$14.7M Sell
80,841
-381
-0.5% -$65.7K 1.66% 24
2023
Q4 		$12.6M Sell
81,222
-5,369
-6% -$783K 1.52% 24
2023
Q3 		$12.9M Sell
86,591
-2,190
-2% -$321K 1.69% 24
2023
Q2 		$12M Sell
88,781
-4,890
-5% -$717K 1.56% 25
2023
Q1 		$14.9M Sell
93,671
-1,825
-2% -$279K 1.85% 24
2022
Q4 		$15.4M Sell
95,496
-350
-0.4% -$53.7K 1.99% 23
2022
Q3 		$12.9M Sell
95,846
-250
-0.3% -$35.9K 1.87% 22
2022
Q2 		$14.7M Sell
96,096
-458
-0.5% -$70K 2.07% 22
2022
Q1 		$15.7M Sell
96,554
-1,137
-1% -$165K 1.92% 22
2021
Q4 		$13.2M Hold
97,691
– – 1.53% 24
2021
Q3 		$10.5M Hold
97,691
– – 1.37% 25
2021
Q2 		$11M Hold
97,691
– – 1.45% 24
2021
Q1 		$10.6M Hold
97,691
– – 1.51% 23
2020
Q4 		$10.5M Sell
97,691
-80
-0.1% -$7.69K 1.48% 24
2020
Q3 		$8.56M Hold
97,771
– – 1.34% 24
2020
Q2 		$9.6M Hold
97,771
– – 1.63% 22
2020
Q1 		$7.45M Sell
97,771
-2,600
-3% -$221K 1.46% 23
2019
Q4 		$8.89M Hold
100,371
– – 1.37% 26
2019
Q3 		$7.6M Sell
100,371
-2,800
-3% -$192K 1.26% 27
2019
Q2 		$7.5M Sell
103,171
-700
-0.7% -$55K 1.26% 27
2019
Q1 		$8.37M Sell
103,871
-6,777
-6% -$554K 1.44% 27
2018
Q4 		$10.2M Buy
110,648
+280
+0.3% +$24.6K 1.97% 20
2018
Q3 		$10.4M Sell
110,368
-700
-0.6% -$66.4K 1.81% 22
2018
Q2 		$10.3M Sell
111,068
-483
-0.4% -$47.2K 1.9% 21
2018
Q1 		$10.6M Buy
111,551
+613
+0.6% +$67.3K 1.95% 21
2017
Q4 		$10.7M Hold
110,938
– – 1.95% 22
2017
Q3 		$9.86M Sell
110,938
-2,600
-2% -$198K 1.95% 22
2017
Q2 		$8.23M Sell
113,538
-2,700
-2% -$182K 1.67% 24
2017
Q1 		$7.57M Sell
116,238
-333
-0.3% -$20.9K 1.57% 24
2016
Q4 		$7.3M Sell
116,571
-100
-0.1% -$6.1K 1.54% 25
2016
Q3 		$7.36M Buy
116,671
+1,637
+1% +$106K 1.56% 25
2016
Q2 		$7.12M Sell
115,034
-170
-0.1% -$10.4K 1.55% 26
2016
Q1 		$6.58M Buy
115,204
+300
+0.3% +$16.7K 1.46% 26
2015
Q4 		$6.81M Sell
114,904
-1,332
-1% -$76.7K 1.56% 26
2015
Q3 		$6.32M Sell
116,236
-18,350
-14% -$1.19M 1.52% 27
2015
Q2 		$9.04M Sell
134,586
-4,575
-3% -$299K 2.1% 19
2015
Q1 		$8.15M Sell
139,161
-9,963
-7% -$602K 1.94% 21
2014
Q4 		$9.76M Sell
149,124
-6,700
-4% -$422K 2.27% 16
2014
Q3 		$9M Sell
155,824
-2,930
-2% -$163K 2.27% 16
2014
Q2 		$8.96M Sell
158,754
-984
-0.6% -$51.6K 2.23% 15
2014
Q1 		$8.21M Sell
159,738
-3,000
-2% -$152K 2.12% 18
2013
Q4 		$8.59M Sell
162,738
-7,967
-5% -$392K 2.28% 16
2013
Q3 		$7.64M Sell
170,705
-3,590
-2% -$159K 2.16% 18
2013
Q2 		$7.21M Buy
+174,295
New +$7.62M 2.16% 18

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Harvey Investment Company's ABBV Position: Q2 2026 in Review

Harvey Investment Company reduced its AbbVie (ABBV) stake by 3% in Q2 2026, selling an estimated $509K and leaving 76,719 shares worth $19.3M. The position accounts for 2.1% of the portfolio, ranked #20.

Harvey Investment Company first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Harvey Investment Company held 76,719 shares of AbbVie worth $19.3M as of Q2 2026.
  • Harvey Investment Company sold 2,367 AbbVie shares in Q2 2026, an estimated $509K.
  • AbbVie made up 2.1% of Harvey Investment Company's portfolio in Q2 2026, its #20 holding.
  • Harvey Investment Company first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Harvey Investment Company's 13F filing for Q2 2026, filed 22 Jul 2026.